
Mastel10 mg
ACI Limited
Mizolastine is a second-generation (non-sedating) H1-antihistamine used for the symptomatic relief of allergic conditions.
Mizolastine is a second-generation (non-sedating) H1-antihistamine used for the symptomatic relief of allergic conditions. Its evidence-based uses include:
Mizolastine is a symptomatic treatment only; it does not address the underlying cause of allergic disease and is not indicated for the treatment of acute anaphylaxis or bronchospasm.
| Population | Recommended Dose |
|---|---|
| Adults and adolescents ≥ 12 years | Mizolastine 10 mg orally once daily |
| Children under 12 years | Not recommended; safety and efficacy not established |
| Population | Recommended Dose |
|---|---|
| Adults and adolescents ≥ 12 years | Mizolastine 10 mg orally once daily |
| Frequency | Side Effects |
|---|---|
| Common | Drowsiness (mild), dry mouth, headache, fatigue, dizziness |
| Uncommon | Weight gain, gastrointestinal upset (nausea, abdominal discomfort) |
| Rare but serious | Cardiac rhythm disturbances, including QT-interval prolongation and, rarely, ventricular arrhythmia (torsades de pointes), particularly when contraindicated combinations are used; hypersensitivity reactions including angioedema and skin rash |
Patients should seek prompt medical attention for palpitations, fainting, or signs of an allergic reaction while taking Mizolastine.
Mizolastine is contraindicated in the following situations, which are true absolute contraindications:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.